NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, will participate in the 7th Annual Evercore HealthCONx Conference, being held at the Loews Coral Gables Hotel, in Florida on December 3-5, 2024. The fireside chat is scheduled to take place on Tuesday, December 3, at 10:00 AM ET.A live webcast of the fireside chat will be available on the Events page, located within ...Full story available on Benzinga.com
TG Therapeutics is a New York-based commercial-stage biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of B-cell diseases.